Mahmoud I Abdel-Aziz,Simone Hashimoto,Anne H Neerincx,Eric G Haarman,Alexander Cecil,Jutta Lintelmann,Michael Witting,Stefanie M Hauck,Nikki Kerssemakers,Joris C Verster,Corinna Bang,Andre Franke,Barbara S Dierdorp,Tamara Dekker,Nariman K A Metwally,Jan Willem Duitman,René Lutter,Mario Gorenjak,Antoaneta A Toncheva,Parastoo Kheiroddin,Susanne Harner,Susanne Brandstetter,Christine Wolff,Paula Corcuera-Elosegui,Leyre López-Fernández,Javier Perez-Garcia,Mario Martin Almeida,Olaia Sardón-Prado,Maria Pino-Yanes,Uroš Potočnik,Michael Kabesch,Susanne J H Vijverberg,Aletta D Kraneveld,Anke H Maitland-van der Zee,
{"title":"Metabotypes are linked to uncontrolled childhood asthma, gut microbiota, and systemic inflammation.","authors":"Mahmoud I Abdel-Aziz,Simone Hashimoto,Anne H Neerincx,Eric G Haarman,Alexander Cecil,Jutta Lintelmann,Michael Witting,Stefanie M Hauck,Nikki Kerssemakers,Joris C Verster,Corinna Bang,Andre Franke,Barbara S Dierdorp,Tamara Dekker,Nariman K A Metwally,Jan Willem Duitman,René Lutter,Mario Gorenjak,Antoaneta A Toncheva,Parastoo Kheiroddin,Susanne Harner,Susanne Brandstetter,Christine Wolff,Paula Corcuera-Elosegui,Leyre López-Fernández,Javier Perez-Garcia,Mario Martin Almeida,Olaia Sardón-Prado,Maria Pino-Yanes,Uroš Potočnik,Michael Kabesch,Susanne J H Vijverberg,Aletta D Kraneveld,Anke H Maitland-van der Zee,","doi":"10.1016/j.jaci.2025.04.017","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nChildhood asthma has been linked to distinct metabolomic profiles.\r\n\r\nOBJECTIVE\r\nTo identify phenotypes (metabotypes) in children with moderate-to-severe asthma through integrative fecal and serum metabolome analysis.\r\n\r\nMETHODS\r\nChildren from the Systems Pharmacology Approach to Uncontrolled Pediatric Asthma cohort with Global Initiative for Asthma treatment step ≥3 were recruited. Asthma control was defined by the Asthma Control Test and annual exacerbation history. Targeted metabolomics profiling of feces and serum was performed using liquid chromatography and flow injection electrospray ionization-triple quadrupole mass spectrometry. Similarity Network Fusion integrated fecal and serum metabolome profiles, followed by spectral clustering. Clusters were analyzed for differences in asthma characteristics, food diaries, fecal microbiota composition, and levels of serum inflammatory markers and blood cells.\r\n\r\nRESULTS\r\nIntegrative fecal and serum metabolome analysis of 92 children with moderate-to-severe asthma (median age: 11.5 years, 34% female) revealed three metabotypes. Metabotype1 had the lowest percentage of allergic rhinitis, with elevated serum ceramides and triglycerides. Metabotype2 had higher odds of asthma control, the highest percentage of children with ≥4 months of breastfeeding, reduced sugar intake, lowest levels of blood neutrophils and serum inflammatory markers, and with elevated serum acylcarnitines and ω-3 fatty acids. Metabotype3 included the highest percentage of uncontrolled asthma patients, with decreased serum cholesteryl esters, phosphatidylcholines, and sphingomyelins, elevated fecal amino acids, and reduced fecal microbiota diversity.\r\n\r\nCONCLUSIONS\r\nMetabotypes in children with moderate-to-severe asthma are linked to asthma control, distinct fecal microbiota and systemic inflammatory patterns. The findings suggest that metabotyping can be valuable in precision medicine approaches for asthma.","PeriodicalId":14936,"journal":{"name":"Journal of Allergy and Clinical Immunology","volume":"19 1","pages":""},"PeriodicalIF":11.4000,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Allergy and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jaci.2025.04.017","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
Childhood asthma has been linked to distinct metabolomic profiles.
OBJECTIVE
To identify phenotypes (metabotypes) in children with moderate-to-severe asthma through integrative fecal and serum metabolome analysis.
METHODS
Children from the Systems Pharmacology Approach to Uncontrolled Pediatric Asthma cohort with Global Initiative for Asthma treatment step ≥3 were recruited. Asthma control was defined by the Asthma Control Test and annual exacerbation history. Targeted metabolomics profiling of feces and serum was performed using liquid chromatography and flow injection electrospray ionization-triple quadrupole mass spectrometry. Similarity Network Fusion integrated fecal and serum metabolome profiles, followed by spectral clustering. Clusters were analyzed for differences in asthma characteristics, food diaries, fecal microbiota composition, and levels of serum inflammatory markers and blood cells.
RESULTS
Integrative fecal and serum metabolome analysis of 92 children with moderate-to-severe asthma (median age: 11.5 years, 34% female) revealed three metabotypes. Metabotype1 had the lowest percentage of allergic rhinitis, with elevated serum ceramides and triglycerides. Metabotype2 had higher odds of asthma control, the highest percentage of children with ≥4 months of breastfeeding, reduced sugar intake, lowest levels of blood neutrophils and serum inflammatory markers, and with elevated serum acylcarnitines and ω-3 fatty acids. Metabotype3 included the highest percentage of uncontrolled asthma patients, with decreased serum cholesteryl esters, phosphatidylcholines, and sphingomyelins, elevated fecal amino acids, and reduced fecal microbiota diversity.
CONCLUSIONS
Metabotypes in children with moderate-to-severe asthma are linked to asthma control, distinct fecal microbiota and systemic inflammatory patterns. The findings suggest that metabotyping can be valuable in precision medicine approaches for asthma.
期刊介绍:
The Journal of Allergy and Clinical Immunology is a prestigious publication that features groundbreaking research in the fields of Allergy, Asthma, and Immunology. This influential journal publishes high-impact research papers that explore various topics, including asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases. The articles not only report on clinical trials and mechanistic studies but also provide insights into novel therapies, underlying mechanisms, and important discoveries that contribute to our understanding of these diseases. By sharing this valuable information, the journal aims to enhance the diagnosis and management of patients in the future.